Bone biomarkers and risk of fracture in two- and three-year-old Thoroughbreds.

This research attempted to determine if specific bone biomarkers could predict which young (2 – 3 year old) racehorses would be more prone to fractures in the approaching racing season. The study found that these biomarkers were not helpful in making such a prediction.

Understanding the Research

• This research intended to test the validity of using certain bone biomarkers to predict the occurrence of fractures in Thoroughbred racehorses that are aged two and three years old.
• The biomarkers being considered in the study were osteocalcin, PICP (Procollagen Type I C-Peptide), ICTP (Cross-linked C-telopeptide of type I collagen) and CTX-I (Carboxyterminal cross-linked telopeptide of type I collagen).
• The significance of the study lies in its potential to introduce preventative measures and improve animal welfare by preventing fractures in racehorses, which are often catastrophic.

Key Findings of the Study

• The study concluded that the four bone biomarkers considered (osteocalcin, PICP, ICTP, and CTX-I) are not reliable predictors for the risk of fractures in two- and three-year-old Thoroughbreds.
• These findings suggest that the tested biomarkers cannot be used to preemptively identify younger horses that might experience a fracture in the following flat racing season.

Study Limitations and Further Research

• While the study concluded that the four selected bone biomarkers can’t predict fracture risks in young horses, it remains open whether these biomarkers could have predictive value for older horses or under different measuring conditions.
• Future research could explore the potential of using these biomarkers in older populations of horses, or if repeated measures of the same animal over time could yield more predictive information.